Matches in Wikidata for { <http://www.wikidata.org/entity/Q94143474> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q94143474 description "im Oktober 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q94143474 description "wetenschappelijk artikel" @default.
- Q94143474 description "наукова стаття, опублікована в жовтні 2019" @default.
- Q94143474 name "676. Health-Related Quality of Life (HRQoL) as Measured by the 12-Item Medical Outcomes Study Short-Form (SF-12) Among Adults With Community-Acquired Bacterial Pneumonia (CABP) Who Received Either Lefamulin (LEF) or Moxifloxacin (MOX) in Two Phase 3" @default.
- Q94143474 name "676. Health-Related Quality of Life (HRQoL) as Measured by the 12-Item Medical Outcomes Study Short-Form (SF-12) Among Adults With Community-Acquired Bacterial Pneumonia (CABP) Who Received Either Lefamulin (LEF) or Moxifloxacin (MOX) in Two Phase 3" @default.
- Q94143474 type Item @default.
- Q94143474 label "676. Health-Related Quality of Life (HRQoL) as Measured by the 12-Item Medical Outcomes Study Short-Form (SF-12) Among Adults With Community-Acquired Bacterial Pneumonia (CABP) Who Received Either Lefamulin (LEF) or Moxifloxacin (MOX) in Two Phase 3" @default.
- Q94143474 label "676. Health-Related Quality of Life (HRQoL) as Measured by the 12-Item Medical Outcomes Study Short-Form (SF-12) Among Adults With Community-Acquired Bacterial Pneumonia (CABP) Who Received Either Lefamulin (LEF) or Moxifloxacin (MOX) in Two Phase 3" @default.
- Q94143474 prefLabel "676. Health-Related Quality of Life (HRQoL) as Measured by the 12-Item Medical Outcomes Study Short-Form (SF-12) Among Adults With Community-Acquired Bacterial Pneumonia (CABP) Who Received Either Lefamulin (LEF) or Moxifloxacin (MOX) in Two Phase 3" @default.
- Q94143474 prefLabel "676. Health-Related Quality of Life (HRQoL) as Measured by the 12-Item Medical Outcomes Study Short-Form (SF-12) Among Adults With Community-Acquired Bacterial Pneumonia (CABP) Who Received Either Lefamulin (LEF) or Moxifloxacin (MOX) in Two Phase 3" @default.
- Q94143474 P1433 Q94143474-3FB65F61-C500-49B4-93F3-F50697EC5037 @default.
- Q94143474 P1476 Q94143474-98EF7EA2-FA29-44A3-916E-9D9AD98A5A6E @default.
- Q94143474 P2093 Q94143474-010CCA84-0166-409A-BBAC-9720575A6BE8 @default.
- Q94143474 P2093 Q94143474-1F35DEF9-B720-4A49-8FEF-D14B642362C4 @default.
- Q94143474 P2093 Q94143474-370D8A02-D696-488A-B8A8-2E5AB7A693AA @default.
- Q94143474 P2093 Q94143474-6B85CB89-6EEE-4206-8AF8-F4BDC7DB9B03 @default.
- Q94143474 P2093 Q94143474-815AF0A0-9E48-42AE-A016-B83E2A39C4A6 @default.
- Q94143474 P2093 Q94143474-D1A3A638-DE8B-4E8B-8964-11B1349B3469 @default.
- Q94143474 P2093 Q94143474-F2246905-7A94-4A84-A04C-57D67F54CCB9 @default.
- Q94143474 P275 Q94143474-ad985697-6479-47bc-9e0d-2393869ebe0e @default.
- Q94143474 P304 Q94143474-A70B9707-4066-4C7A-8EA1-57CE44857791 @default.
- Q94143474 P31 Q94143474-9507C5A7-223A-4218-AFFD-2D11E2B68FEE @default.
- Q94143474 P356 Q94143474-CF1E69CA-8066-4D7F-8126-BF9C3B9CEFBC @default.
- Q94143474 P433 Q94143474-4D4D7C3C-AA9C-4910-A3D1-3CC735841D26 @default.
- Q94143474 P478 Q94143474-39BBBBF0-5C25-46D8-963E-FC00C8006402 @default.
- Q94143474 P577 Q94143474-75584B80-4A34-4502-8F88-8241BE028A23 @default.
- Q94143474 P6216 Q94143474-4250850b-546e-4da2-8847-2ccc4f1babb5 @default.
- Q94143474 P921 Q94143474-26925F06-CA85-4C18-A26F-20144DCEB027 @default.
- Q94143474 P921 Q94143474-3A86FA8B-76D5-40DA-9550-993C7F52E0C8 @default.
- Q94143474 P932 Q94143474-9905DA00-904C-49F1-8F2B-72E1F0CE0345 @default.
- Q94143474 P356 OFZ360.744 @default.
- Q94143474 P1433 Q27725953 @default.
- Q94143474 P1476 "676. Health-Related Quality of Life (HRQoL) as Measured by the 12-Item Medical Outcomes Study Short-Form (SF-12) Among Adults With Community-Acquired Bacterial Pneumonia (CABP) Who Received Either Lefamulin (LEF) or Moxifloxacin (MOX) in Two Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trials (LEAP 1 and 2)" @default.
- Q94143474 P2093 "Daniel Stein" @default.
- Q94143474 P2093 "David Fitts" @default.
- Q94143474 P2093 "Elizabeth Alexander" @default.
- Q94143474 P2093 "Jennifer Schranz" @default.
- Q94143474 P2093 "Lisa Goldberg" @default.
- Q94143474 P2093 "Sam Colman" @default.
- Q94143474 P2093 "Thomas Lodise" @default.
- Q94143474 P275 Q24082749 @default.
- Q94143474 P304 "S308-S309" @default.
- Q94143474 P31 Q13442814 @default.
- Q94143474 P356 "10.1093/OFID/OFZ360.744" @default.
- Q94143474 P433 "Suppl 2" @default.
- Q94143474 P478 "6" @default.
- Q94143474 P577 "2019-10-23T00:00:00Z" @default.
- Q94143474 P6216 Q50423863 @default.
- Q94143474 P921 Q3776920 @default.
- Q94143474 P921 Q424940 @default.
- Q94143474 P932 "6811025" @default.